127 related articles for article (PubMed ID: 2039214)
1. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
Jorgensen JH; Maher LA; Howell AW
Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
Miyazaki S; Fujikawa T; Kanazawa K; Yamaguchi K
J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.
Powell M; Williams JD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940
[TBL] [Abstract][Full Text] [Related]
5. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Powell M; Seetulsingh P; Williams JD
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.
Cerami AT; Shungu DL
Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.
Yourassowsky E; Van der Linden MP; Crokaert F
Chemotherapy; 1991; 37(1):38-42. PubMed ID: 2013240
[TBL] [Abstract][Full Text] [Related]
8. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of beta-lactamase negative ampicillin resistant Haemophilus influenzae in Mie Prefecture].
Maruyama T; Yoshimura H; Nakamura A; Abe K; Moriguchi Y; Matsushima Y; Furukawa M; Nakano M; Morishita Y; Nobori T
Kansenshogaku Zasshi; 2004 Oct; 78(10):891-7. PubMed ID: 15560379
[TBL] [Abstract][Full Text] [Related]
10. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Billal DS; Hotomi M; Yamanaka N
Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
[No Abstract] [Full Text] [Related]
11. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
Jorgensen JH; Doern GV; Thornsberry C; Preston DA; Redding JS; Maher LA; Tubert T
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):27-32. PubMed ID: 3259490
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both.
Campos JM; Gill CJ; Ahonkhai VI
J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
[TBL] [Abstract][Full Text] [Related]
14. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
15. [Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Furugo I; Takii M; Ueda M; Ishida M
Jpn J Antibiot; 2002 Jun; 55(3):302-10. PubMed ID: 12199114
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
García-Cobos S; Campos J; Lázaro E; Román F; Cercenado E; García-Rey C; Pérez-Vázquez M; Oteo J; de Abajo F
Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
[TBL] [Abstract][Full Text] [Related]
19. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
Seki H; Kasahara Y; Ohta K; Saikawa Y; Sumita R; Yachie A; Fujita S; Koizumi S
Chemotherapy; 1999; 45(1):15-21. PubMed ID: 9876205
[TBL] [Abstract][Full Text] [Related]
20. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
